According to a recent EXPRESS article, pharmaceutical giant Pfizer is looking to maximize its mRNA technology for a second vaccine. The same messenger ribonucleic concept that propelled their COVID-19 vaccine at warp speed is now being applied to a vaccine for influenza. The company announced it will begin testing the vaccine in a Phase 1 clinical trial to test safety and efficacy.
Pfizer’s mRNA Flu Vaccine is Coming
The influenza vaccine was designed with the same mRNA technology as Pfizer’s COVID-19 shot.
Oct 4, 2021
List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
